Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer

Gynecologic Oncology

Volumn 111, Issue 2, 2008, Pages 213-220

  Harry, Vanessa N ^a   Semple, Scott I ^b   Gilbert, Fiona J ^c   Parkin, David E ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Apparent diffusion coefficient; Cervical cancer; Diffusion weighted MRI; Radiotherapy

Indexed keywords

BIOLOGICAL MARKER; CESIUM; CISPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; GYNECOLOGIC CANCER; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPRODUCIBILITY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COHORT STUDIES; COMBINED MODALITY THERAPY; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 55649111574     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.07.048     Document Type: Article

References (43)

1. Hayes C., Padhani A.R., and Leach M.O. Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 15 (2002) 154-163
2. Pickles M.D., Gibbs P., Lowry M., and Turnbull L.W. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24 (2006) 843-847
3. Padhani A.R. Functional MRI for anticancer therapy assessment. Eur J Cancer 38 (2002) 2116-2127
4. Britten R.A., Evans A.J., Allalunis-Turner M.J., Franko A.J., and Pearcey R.G. Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness. Radiother Oncol 39 (1996) 145-153
5. Heppner G.H., and Miller F.R. The cellular basis of tumor progression. Int Rev Cytol 177 (1998) 1-56
6. Oppenheim C., Lamy C., Touze E., Calvet D., Hamon M., Mas J.L., et al. Do transient ischemic attacks with diffusion-weighted imaging abnormalities correspond to brain infarctions?. AJNR Am J Neuroradiol 27 (2006) 1782-1787
7. Sanak D., Nosal' V., Horak D., Bartkova A., Zelenak K., Herzig R., et al. Impact of diffusion-weighted MRI-measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis. Neuroradiology 48 (2006) 632-639
8. Chenevert T.L., Meyer C.R., Moffat B.A., Rehemtulla A., Mukherji S.K., Gebarski S.S., et al. Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. MoI Imaging 1 (2002) 336-343
9. Chenevert T.L., Stegman L.D., Taylor J.M., Robertson P.L., Greenberg H.S., Rehemtulla A., et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 92 (2000) 2029-2036
10. Hamstra D.A., Rehemtulla A., and Ross B.D. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol 25 (2007) 4104-4109
11. Stejskal E., and Tanner T. Spin diffusion measurements: spin echoes in the presence of a time-dependent time gradient. J Chem Phys 42 (1965) 288-292
12. Ross B.D., Chenevert T.L., Kim B., and Ben-Yoseph O. Magnetic resonance imaging and spectroscopy: application to experimental neuro-oncology. Q Magn Reson Biol Med 1 (1994) 89-106
13. Zhao M., Pipe J.G., Bonnett J., and Evelhoch J.L. Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. Br J Cancer 73 (1996) 61-64
14. Le Bihan D., Breton E., Lallemand D., Aubin M.L., Vignaud J., and Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168 (1988) 497-505
15. Ross B.D., Moffat B.A., Lawrence T.S., Mukherji S.K., Gebarski S.S., Quint D.J., et al. Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther 2 (2003) 581-587
16. Lee K.C., Moffat B.A., Schott A.F., Layman R., Ellingworth S., Juliar R., et al. Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy. Clin Cancer Res 13 (2007) 443-450
17. Chenevert T.L., McKeever P.E., and Ross B.D. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 3 (1997) 1457-1466
18. Galons J.P., Altbach M.I., Paine-Murrieta G.D., Taylor C.W., and Gillies R.J. Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1 (1999) 113-117
19. 1H-NMR spectroscopy in vivo. MAGMA 8 (1999) 20-26
20. Jennings D., Hatton B.N., Guo J., Galons J.P., Trouard T.P., Raghunand N., et al. Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. Neoplasia 4 (2002) 255-262
21. Moffat B.A., Chenevert T.L., Lawrence T.S., Meyer C.R., Johnson T.D., Dong Q., et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U.S.A. 102 (2005) 5524-5529
22. Mardor Y., Pfeffer R., Spiegelmann R., Roth Y., Maier S.E., Nissim O., et al. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 21 (2003) 1094-1100
23. Hamstra D.A., Chenevert T.L., Moffat B.A., Johnson T.D., Meyer C.R., Mukherji S.K., et al. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U.S.A. 102 (2005) 16759-16764
24. Theilmann R.J., Borders R., Trouard T.P., Xia G., Outwater E., Ranger-Moore J., et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 6 (2004) 831-837
25. Buijs M., Kamel I.R., Vossen J.A., Georgiades C.S., Hong K., and Geschwind J.F. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. J Vasc Interv Radiol 18 (2007) 957-963
26. Dzik-Jurasz A., Domenig C., George M., Wolber J., Padhani A., Brown G., et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 360 (2002) 307-308
27. DeVries A.F., Kremser C., Hein P.A., Griebel J., Krezcy A., Ofner D., et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 56 (2003) 958-965
28. Miller A.B., Hoogstraten B., Staquet M., and Winkler A. Reporting results of cancer treatment. Cancer 47 (1981) 207-214
29. James K., Eisenhauer E., Christian M., Terenziani M., Vena D., Muldal A., et al. Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst 91 (1999) 523-528
30. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-310
31. Leimgruber A., Ostermann S., Yeon E.J., Buff E., Maeder P.P., Stupp R., et al. Perfusion and diffusion MRI of glioblastoma progression in a four-year prospective temozolomide clinical trial. Int J Radiat Oncol Biol Phys 64 (2006) 869-875
32. Tomura N., Narita K., Izumi J., Suzuki A., Anbai A., Otani T., et al. Diffusion changes in a tumor and peritumoral tissue after stereotactic irradiation for brain tumors: possible prediction of treatment response. J Comput Assist Tomogr 30 (2006) 496-500
33. Sugahara T., Korogi Y., Kochi M., Ikushima I., Shigematu Y., Hirai T., et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9 (1999) 53-60
34. Naganawa S., Sato C., Kumada H., Ishigaki T., Miura S., and Takizawa O. Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 15 (2005) 71-78
35. Manenti G., Squillaci E., Di Roma M., Carlani M., Mancino S., and Simonetti G. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging. Radiol Med 111 (2006) 1124-1133
36. Herneth A.M., Guccione S., and Bednarski M. Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization. Eur J Radiol 45 (2003) 208-213
37. Mardor Y., Roth Y., Ochershvilli A., Spiegelmann R., Tichler T., Daniels D., et al. Pre-treatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. Neoplasia 6 (2004) 136-142
38. Kremser C., Judmaier W., Hein P., Griebel J., Lukas P., and de Vries A. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol 179 (2003) 641-649
39. Deng J., Miller F.H., Rhee T.K., Sato K.T., Mulcahy M.F., Kulik L.M., et al. Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization. J Vasc Interv Radiol 17 (2006) 1195-1200
40. Uhl M., Saueressig U., Koehler G., Kontny U., Niemeyer C., Reichardt W., et al. Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas. Pediatr Radiol 36 (2006) 1306-1311
41. Chinnaiyan A.M., Prasad U., Shankar S., Hamstra D.A., Shanaiah M., Chenevert T.L., et al. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci U.S.A. 97 (2000) 1754-1759
42. McVeigh P.Z., Syed A.M., Milosevic M., Fyles A., and Haider M.A. Diffusion-weighted MRI in cervical cancer. Eur Radiol 18 (2008) 1058-1064
43. Zhang Y., Liang B.L., Gao L., Ye R.X., Shen J., and Zhong J.L. Diffusion weighted imaging features of normal uterine cervix and cervical carcinoma. Ai Zheng 26 (2007) 508-512